In June this year, Paul Henderson received test results showing elevated PSA levels. In this weekly diary, he will be sharing ...

Michael, David, Paul – the names of just three of our readers who have had to take matters into their own hands when it comes ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

3 Cancer Stocks in Focus J&J’s Oncology segment comprises around 27% of its total revenues. Its oncology sales rose 22.3% on an operational basis in the second quarter of 2025 to $6.3 billion ...

Researchers identified that triterpene glycosides from the starfish Solaster pacificus can kill drug-resistant prostate ...

One in 6 Black men will be diagnosed with prostate cancer in their lives, even more if disease runs in their family. But most ...

Designating GG1 on biopsy as noncancer without considering the prognostic values of adverse clinical features may lead to undertreatment and an increased risk of cancer-specific death in men with ...

A man from Herefordshire has claimed that watching an interview with Sir Chris Hoy, in which he opened up about his terminal ...

ORIC's pipeline shows early promise, especially ORIC-944 in prostate cancer and well-funded through 2027, but safety risks ...

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

James Van Der Beek shared that working on the Legally Blonde prequel series, Elle, has been a welcome escape as he battles ...

HOXB13, a B-class homeobox transcription factor, sits at the hub of developmental gene networks yet has emerged as a ...